Partial response seen with Lilly melanoma drug

Partial response seen with Lilly melanoma drug
Some patients in a small mid-stage clinical trial had a partial response to treatment with an experimental drug being developed by Eli Lilly and Co for advanced melanoma, the deadliest form of skin cancer, according to a summary of the data.

Read more on Reuters via Yahoo! News

More Meth Drug Addiction Info:

• Vision Shopsters Official Blog » Blog Archive » The Future of Pain …
• An experimental cancer drug may work in melanoma tumors in brain …
• Partial Page Rendering Using Hidden Iframe | Software technology …
• Partial response seen with Lilly melanoma drug (Reuters) « debt …
• Alder, Bristol Arthritis Drug Shows “Outstanding” Results in Trial …
• Ischemix Faces Moment of Truth with Mid–Stage Heart Drug Trial …
• Looking past “the little stuff” at Eli Lilly… | footnoted.com
• Two early-stage Glaxo drugs show melanoma promise
• How Scientists Work | ENGLISH ARTICLES
• Earnings Scorecard: Eli Lilly | Daily Markets